Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 2011. The report details a specific share repurchase transaction executed on May 24, 2011, pursuant to shareholder authority granted at the Annual General Meeting on May 5, 2011.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. It focuses exclusively on capital structure and share repurchase activity.
- Shares Purchased: 450,000 Ordinary shares of 25 pence each.
- Price Range: Highest price paid was 1,325.00 pence per share; lowest price paid was 1,311.00 pence per share.
- Treasury Holdings (Settled): 494,799,284 shares (8.75% of total issued share capital).
- Treasury Holdings (Including Unsettled): 496,149,284 shares (9.61% of total voting rights).
- Shares in Issue (Excluding Treasury): 5,161,845,490 shares.
Material Changes
The primary material change is the reduction of outstanding shares through the repurchase of 450,000 shares. Consequently, the percentage of total voting rights held in Treasury increased to 9.61% when including unsettled purchases. The filing does not provide comparative data to prior periods regarding these specific metrics.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities and is made in conformity with the Financial Services Authority's Disclosure and Transparency Rules.
Investor Verification Checklist
- Verify the total number of shares held in Treasury (494,799,284 settled) against the company's latest capitalization table.
- Confirm the total voting rights denominator (5,161,845,490 shares) for disclosure threshold calculations under FSA rules.
- Check the settlement status of the 450,000 shares purchased on May 24, 2011, to reconcile the difference between settled and total treasury holdings.